When Should I Have CAH Blood Tests in the Morning?
At a Glance
For CAH treatment monitoring, blood tests are scheduled early in the morning before the daily glucocorticoid dose to capture overnight hormone control. Never skip or delay replacement or emergency medication if you are sick or a lab visit runs late.
Your endocrinologist asks you to get your blood drawn first thing in the morning, before taking your first daily dose of glucocorticoid medication, because this provides a standardized pre-dose “trough” snapshot of your disease control. Taking your medication before the blood draw can rapidly alter your hormone levels, making it difficult for your doctor to tell if your overnight medication dose was actually sufficient [1][2].
Important Safety Warning: Never Risk an Adrenal Crisis for a Blood Test
While your doctor wants a pre-dose snapshot, you should never delay or skip your glucocorticoid replacement if doing so puts your health at risk.
- If you are sick: Follow your sick-day rules. Take your stress dose or emergency injection immediately. Do not delay medication for a routine lab test.
- If the lab is delayed: If your appointment is running late and you are feeling unwell or passing your scheduled dose time, take your medication. Do not risk an adrenal crisis while sitting in a waiting room. Just write down the exact time you took your pill and tell your endocrinology team.
The Morning Snapshot: Your Body’s Natural Clock
The human body operates on a 24-hour internal clock known as a circadian rhythm. In a person without Congenital Adrenal Hyperplasia (CAH), the brain sends a signal called ACTH (adrenocorticotropic hormone) to the adrenal glands, telling them to produce cortisol. This ACTH signal naturally peaks in the early morning [3][4].
In the common simple virilizing form of classic CAH, the body has significantly reduced activity of an enzyme (21-hydroxylase) needed to make cortisol. Because cortisol levels are low, the brain continues sending ACTH signals to stimulate the adrenal glands. This causes a buildup of hormone precursors, like 17-OHP (17-hydroxyprogesterone), and adrenal androgens [3][4]. Testing first thing in the morning captures a standardized pre-dose snapshot, helping your doctor evaluate how much your adrenal glands are being stimulated after the longest gap between medication doses.
How Medication Changes the Results
The glucocorticoid medication you take (such as hydrocortisone, prednisone, or dexamethasone) replaces the missing cortisol. When you take a dose, it tells your brain to lower the ACTH signal, which reduces the production of 17-OHP and androgens [5].
Different medications absorb at different rates, but short-acting medications like hydrocortisone can change your lab results relatively quickly. Research shows that after taking hydrocortisone, the levels of 17-OHP and androstenedione can drop substantially in less than an hour [6][5].
If you take your medication before your blood test, the lab results may just reflect the immediate effect of that single pill rather than your overall overnight control [6]. A pre-dose test provides a vital baseline to help your endocrinologist evaluate whether your medication is effectively covering you between doses [1].
Consistency is Key
Because hormone levels fluctuate so dramatically throughout the day based on your natural rhythms and medication times, a single blood test is just a snapshot [6]. For that snapshot to be useful, the conditions should be as similar as possible every time you test.
- Time it the same way: Try to get your blood drawn at the same time of morning, with the same amount of time having passed since your last evening dose [7]. Tell your care team exactly when your last dose was taken.
- Fasting is rarely needed: Unless your doctor has ordered other tests (like a fasting glucose test), you do not need to fast for routine CAH steroid monitoring. Drink plenty of water so you are hydrated for the blood draw, and never delay your medication solely because you are fasting.
- Use the same laboratory: Different labs use different methods to measure hormones. Some older methods (immunoassays) can show higher 17-OHP levels due to cross-reactivity compared to newer, highly specific methods (like LC-MS/MS) [8][2]. Sticking to one lab prevents false alarms caused by testing differences.
The Big Picture: Balancing the Numbers
Remember that your doctor is not looking for a “perfect” or completely normal morning 17-OHP number. Mildly elevated 17-OHP is often an intentional treatment target. Pushing your glucocorticoid dose too high just to make your 17-OHP perfectly normal can lead to dangerous side effects of overtreatment, such as poor growth, weight gain, high blood pressure, and bone loss [9][10].
Your endocrinologist uses this morning pre-dose snapshot alongside other tests (such as renin and electrolytes, if you take fludrocortisone) and your physical symptoms to find the lowest effective medication dose that keeps you healthy and feeling well [11][12].
Common questions in this guide
Why are CAH blood tests usually done first thing in the morning?
Should I take my morning glucocorticoid before a CAH blood test?
What should I do if the CAH lab appointment is delayed?
Do CAH blood tests require fasting?
Why should my CAH blood tests be done at the same time and lab?
Does a high morning 17-OHP result mean my CAH medication needs to be increased?
Related questions
Show more
Get notified when new evidence is published on Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (12)
- 1
First Morning Pregnanetriol and 17-Hydroxyprogesterone Correlated Significantly in 21-Hydroxylase Deficiency.
Itonaga T, Izawa M, Hamajima T, Hasegawa Y
Frontiers in endocrinology 2021; (12()):808254 doi:10.3389/fendo.2021.808254.
PMID: 35140686 - 2
Assay of steroids by liquid chromatography-tandem mass spectrometry in monitoring 21-hydroxylase deficiency.
Dahl SR, Nermoen I, Brønstad I, et al.
Endocrine connections 2018; (7(12)):1542-1550.
PMID: 30530876 - 3
A quantitative modeling framework to understand the physiology of the hypothalamic-pituitary-adrenal axis and interaction with cortisol replacement therapy.
Bindellini D, Michelet R, Aulin LBS, et al.
Journal of pharmacokinetics and pharmacodynamics 2024; (51(6)):809-824 doi:10.1007/s10928-024-09934-7.
PMID: 38977635 - 4
[Long-term morbidity in congenital adrenal hyperplasia].
Tschaidse L, Quitter F, Hübner A, Reisch N
Der Internist 2022; (63(1)):43-50 doi:10.1007/s00108-021-01223-6.
PMID: 34978615 - 5
Proof of concept for a superior therapeutic index of corticosterone compared with hydrocortisone in patients with congenital adrenal hyperplasia.
Kyle CJ, Boyle LD, Nixon M, et al.
European journal of endocrinology 2024; (191(6)):535-544 doi:10.1093/ejendo/lvae144.
PMID: 39546623 - 6
An integrated PK-PD model for cortisol and the 17-hydroxyprogesterone and androstenedione biomarkers in children with congenital adrenal hyperplasia.
Al-Kofahi M, Ahmed MA, Jaber MM, et al.
British journal of clinical pharmacology 2021; (87(3)):1098-1110 doi:10.1111/bcp.14470.
PMID: 32652643 - 7
Hormonal circadian rhythms in patients with congenital adrenal hyperplasia: identifying optimal monitoring times and novel disease biomarkers.
Debono M, Mallappa A, Gounden V, et al.
European journal of endocrinology 2015; (173(6)):727-37 doi:10.1530/EJE-15-0064.
PMID: 26340969 - 8
Therapy monitoring in congenital adrenal hyperplasia by dried blood samples.
Wieacker I, Peter M, Borucki K, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2015; (28(7-8)):867-71.
PMID: 25781526 - 9
Biomarkers in congenital adrenal hyperplasia.
Bacila IA, Lawrence NR, Badrinath SG, et al.
Clinical endocrinology 2024; (101(4)):300-310 doi:10.1111/cen.14960.
PMID: 37608608 - 10
HYDROCORTISONE THERAPY AND GROWTH TRAJECTORY IN CHILDREN WITH CLASSICAL CONGENITAL ADRENAL HYPERPLASIA.
Bizzarri C, Improda N, Maggioli C, et al.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2017; (23(5)):546-556 doi:10.4158/EP171751.OR.
PMID: 28225306 - 11
The urinary steroidome of treated children with classic 21-hydroxylase deficiency.
Kamrath C, Wettstaedt L, Boettcher C, et al.
The Journal of steroid biochemistry and molecular biology 2017; (165(Pt B)):396-406 doi:10.1016/j.jsbmb.2016.08.006.
PMID: 27544322 - 12
Interpretation of Steroid Biomarkers in 21-Hydroxylase Deficiency and Their Use in Disease Management.
Sarafoglou K, Merke DP, Reisch N, et al.
The Journal of clinical endocrinology and metabolism 2023; (108(9)):2154-2175 doi:10.1210/clinem/dgad134.
PMID: 36950738
This page explains timing for CAH blood tests for educational purposes only and does not replace medical advice. Follow your endocrinology team’s medication and sick-day instructions, and do not postpone emergency glucocorticoid treatment for a routine lab draw.